Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases

Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases

3-Iodothyronamine (T1AM) is the last iodinated thyronamine generated from thyroid hormone alternative metabolism found circulating in rodents and in humans. So far, the physiopathological meaning of T1AM tissue levels is unknown. Much is instead known on T1AM pharmacological effects in rodents. Such...

Full description

Bibliographic Details
Main Authors:	Annunziatina Laurino, Elisa Landucci, Laura Raimondi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-06-01
Series:	Frontiers in Endocrinology
Subjects:	3-iodothyronamine 3-iodothyroacetic acid histamine trace amine-associated receptors monoamine oxidases
Online Access:	https://www.frontiersin.org/article/10.3389/fendo.2018.00290/full

Similar Items

Commentary: 3-Iodothyronamine Reduces Insulin Secretion In Vitro via a Mitochondrial Mechanism
by: Annunziatina Laurino, et al.
Published: (2018-02-01)

Redox Properties of 3-Iodothyronamine (T1AM) and 3-Iodothyroacetic Acid (TA1)
by: Manuela Gencarelli, et al.
Published: (2022-02-01)

Exogenous 3-Iodothyronamine (T<sub>1</sub>AM) Can Affect Phosphorylation of Proteins Involved on Signal Transduction Pathways in In Vitro Models of Brain Cell Lines, but These Effects Are Not Strengthened by Its Catabolite, 3-Iodothyroacetic Acid (TA<sub>1</sub>)
by: Lavinia Bandini, et al.
Published: (2022-08-01)

3-Iodothyronamine Affects Thermogenic Substrates’ Mobilization in Brown Adipocytes
by: Manuela Gencarelli, et al.
Published: (2020-05-01)

Brain Histamine Modulates the Antidepressant-Like Effect of the 3-Iodothyroacetic Acid (TA1)
by: Annunziatina Laurino, et al.
Published: (2019-05-01)

Abnormal brain development of monoamine oxidase mutant zebrafish and impaired social interaction of heterozygous fish
by: Diego Baronio, et al.
Published: (2022-03-01)

Recent progress in directed evolution of stereoselective monoamine oxidases
by: Jiaqi Duan, et al.
Published: (2019-09-01)

Uptake of 3‐iodothyronamine hormone analogs inhibits the growth and viability of cancer cells
by: Michael Rogowski, et al.
Published: (2017-04-01)

Modulating Liver Cholesterol Metabolism by 3-Iodothyronamine
by: Nasrin KAZEMIPOUR, et al.
Published: (2017-07-01)

Methylxanthines Inhibit Primary Amine Oxidase and Monoamine Oxidase Activities of Human Adipose Tissue
by: Wiem Haj Ahmed, et al.
Published: (2020-04-01)

Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities
by: Zofia Chrienova, et al.
Published: (2022-12-01)

3-Iodothyronamine, a Novel Endogenous Modulator of Transient Receptor Potential Melastatin 8?
by: Noushafarin Khajavi, et al.
Published: (2017-08-01)

New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection
by: Lorenza Bellusci, et al.
Published: (2017-12-01)

Role of Monoamine Oxidase Activity in Alzheimer’s Disease: An Insight into the Therapeutic Potential of Inhibitors
by: Tapan Behl, et al.
Published: (2021-06-01)

Hospitalized Patients' Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist's Classroom-Based Education
by: Richard G. Wenzel, et al.
Published: (2010-06-01)

T1AM/TAAR1 System Reduces Inflammatory Response and β-Amyloid Toxicity in Human Microglial HMC3 Cell Line
by: Beatrice Polini, et al.
Published: (2023-07-01)

Monoamine Oxidase-B Inhibitor Reduction in Pro-Inflammatory Cytokines Mediated by Inhibition of cAMP-PKA/EPAC Signaling
by: Edward E. Putnins, et al.
Published: (2021-11-01)

Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
by: Makoto Naoi, et al.
Published: (2022-09-01)

Nitrogen heterocycles as potential monoamine oxidase inhibitors: Synthetic aspects
by: Pravin O. Patil, et al.
Published: (2014-12-01)

The inhibition of monoamine oxidase by harmine derivatives
by: Theo Myburg, et al.
Published: (2022-01-01)

Correlation between total nitrite/nitrate concentrations and monoamine oxidase (types A and B) and semicarbazide-sensitive amine oxidase enzymatic activities in human mesenteric arteries from non-diabetic and type 2 diabetic patients
by: S.F. Nunes, et al.
Published: (2012-01-01)

Correlation between total nitrite/nitrate concentrations and monoamine oxidase (types A and B) and semicarbazide-sensitive amine oxidase enzymatic activities in human mesenteric arteries from non-diabetic and type 2 diabetic patients
by: S.F. Nunes, et al.
Published: (2012-01-01)

Microbial Metabolite Urolithin B Inhibits Recombinant Human Monoamine Oxidase A Enzyme
by: Rajbir Singh, et al.
Published: (2020-06-01)

Quercetin and Related Chromenone Derivatives as Monoamine Oxidase Inhibitors: Targeting Neurological and Mental Disorders
by: Priyanka Dhiman, et al.
Published: (2019-01-01)

Synthesis and Monoamine Oxidase Inhibition Properties of 4-(2-Methyloxazol-4-yl)benzenesulfonamide
by: Anton A. Shetnev, et al.
Published: (2024-03-01)

Thyroid Hormone, Thyroid Hormone Metabolites and Mast Cells: A Less Explored Issue
by: Elisa Landucci, et al.
Published: (2019-03-01)

Dual Targeting Ligands—Histamine H<sub>3</sub> Receptor Ligands with Monoamine Oxidase B Inhibitory Activity—In Vitro and In Vivo Evaluation
by: Dorota Łażewska, et al.
Published: (2022-10-01)

Structures and mechanism of the monoamine oxidase family
by: Gaweska Helena, et al.
Published: (2011-10-01)

Colorimetric dopamine detection based on immobilized monoamine oxidase through silver nanoparticles
by: Shin, Gounhanul, et al.
Published: (2023)

SAR and molecular mechanism studies of monoamine oxidase inhibition by selected chalcone analogs
by: Raed Shalaby, et al.
Published: (2019-01-01)

Monoamine Oxidase A is a Major Mediator of Mitochondrial Homeostasis and Glycolysis in Gastric Cancer Progression
by: Chen L, et al.
Published: (2020-09-01)

The Rate of Histamine Degradation by Diamine Oxidase Is Compromised by Other Biogenic Amines
by: Sònia Sánchez-Pérez, et al.
Published: (2022-05-01)

Histamine intolerance caused by Diamine Oxidase (DAO) deficiency – case report
by: Aleksandra Iwona Zimna, et al.
Published: (2022-09-01)

Why Monoamine Oxidase B Preferably Metabolizes <i>N</i>-Methylhistamine over Histamine: Evidence from the Multiscale Simulation of the Rate-Limiting Step
by: Aleksandra Maršavelski, et al.
Published: (2022-02-01)

Effects of Natural Monoamine Oxidase Inhibitors on Anxiety-Like Behavior in Zebrafish
by: Oihane Jaka, et al.
Published: (2021-05-01)

Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
by: Narayan D. Chaurasiya, et al.
Published: (2022-07-01)

Computational Insights into β-Carboline Inhibition of Monoamine Oxidase A
by: Alja Prah, et al.
Published: (2022-10-01)

Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development
by: Reem Aljanabi, et al.
Published: (2021-10-01)

Association between Single Nucleotide Polymorphisms in Monoamine Oxidase and the Severity of Addiction to Betel Quid
by: Chung-Chieh Hung, et al.
Published: (2024-01-01)

Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors
by: Jong Min Oh, et al.
Published: (2020-05-01)